Cf Bankshares Inc. (CFBK) · Oct 27, 2026 · Earnings

CF Bankshares earnings meet estimates as loan growth accelerates

In line — Diluted EPS $0.91 vs ~$0.91 consensus

CF Bankshares’ Q3 earnings matched consensus, while commercial lending, fee income and margin expansion strengthened the growth story amid higher expenses and credit watchpoints.

CFBank is in the middle of a commercial-banking expansion across five Ohio and Indiana metro markets, adding bankers and building fuller lending, deposit, treasury-management and mortgage relationships. That strategy was already visible before this release; the new information is that loan production and fee growth are beginning to show up in the numbers. The company’s strategy centers on scaling its commercial and residential lending platforms.

MetricQ3 2026Comparison
Diluted EPS$0.91$0.90 Q2 2026; $0.36 Q3 2025; ~$0.91 consensus
Net income$6.0M$5.9M Q2; $2.3M Q3 2025
PPNR$7.9M$8.2M Q2; $7.8M Q3 2025
Net interest margin2.96%2.93% Q2; 2.76% Q3 2025
Gross loans and leases$1.9BUp 2.2% from Q2; up 5.7% from Dec. 31, 2025
Noninterest expense$8.8MUp 5.1% Q/Q; up 13.4% Y/Y
Nonaccrual loans$20.4M1.10% of loans; $20.8M in Q2

The scorecard is in line, not a clean earnings beat. Diluted EPS was $0.91, essentially matching the published consensus of about $0.91; revenue expectations were also around $16.8 million, versus roughly $16.7 million of net interest income plus noninterest income in the release. The release therefore confirms the earnings trajectory rather than materially resetting it.

The underlying commercial-growth engine is stronger than the headline EPS suggests. Q3 produced $79 million of commercial loan fundings and $42 million of net commercial loan growth, taking year-to-date fundings to $357 million and net growth to $129 million. Gross loans rose 5.7% from year-end, led primarily by commercial real estate, construction and C&I balances. This is meaningful progress on the stated strategy, although the mix is concentrated in commercial real estate and construction rather than being purely C&I relationship growth.

Margins and fee income are improving, but the bank is paying upfront for expansion. NIM increased to 2.96%, up three basis points sequentially and 20 basis points year over year, while customer fees rose 8% sequentially and 32% year to date. Against that, noninterest expense rose 13.4% year over year, including recruiting fees and signing bonuses tied to the commercial-team buildout. The business is generating better revenue mix, but the payoff from the new hires is not yet fully visible in quarterly PPNR, which fell to $7.9 million from $8.2 million in Q2.

Credit costs have normalized sharply, but asset quality still deserves attention as the balance sheet grows. Provision expense fell to $551,000 from $5.1 million a year earlier, and the quarter’s past-due increase was partly reversed after two loans were brought current. However, nonaccrual loans remained above year-end levels at $20.4 million, while loans 30 days or more past due increased to $30.8 million from $20.4 million in Q2. The credit picture is better than last year’s charge-off-heavy comparison, but not risk-free.

Bottom line: This was an earnings-in-line quarter, but the more important business signal was continued commercial loan and fee growth. The expansion is gaining traction, though higher staffing costs and elevated past-due loans mean the next proof point is whether growth converts into better operating leverage without renewed credit losses.

What to watch next

Q4 results, early 2027

Original filing on SEC EDGAR

CF Bankshares earnings meet estimates as loan growth accelerates | CFBK Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.